| Members |
targetComponentId |
| Diltiazem 360mg m/r tablet |
Diltiazem only product in oral dose form |
| Diltiazem 360mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
| Diltiazem 420mg m/r tablet |
Diltiazem only product in oral dose form |
| Diltiazem 420mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 420mg m/r capsule |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 420mg prolonged-release oral capsule |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 5mg/mL solution |
Product containing only diltiazem in parenteral dose form (medicinal product form) |
| Dimeglumine gadopentetate |
Product containing gadopentetic acid (medicinal product) |
| Dimeglumine gadopentetate |
Product containing gadopentetic acid (medicinal product) |
| Dimeglumine gadopentetate 469.01mg/mL injection solution prefilled syringe |
Gadopentetic acid only product |
| Dimeglumine gadopentetate 469.01mg/mL injection solution vial |
Gadopentetic acid only product |
| Dingo dog breed |
Canis lupus dingo |
| Dinoprostone 10mg insert |
Dinoprostone 10 mg prolonged-release vaginal pessary |
| Dinoprostone 10mg suppository |
Dinoprostone 10 mg prolonged-release vaginal pessary |
| dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion |
Dinoprostone 10 mg/mL solution for injection |
| dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
Dinoprostone 1 mg/mL solution for injection |
| Dioxygenase |
Dioxygenase |
| Dipeptide hydrolase |
Dipeptide hydrolase |
| Dipeptidyl carboxypeptidase II |
Dipeptidyl carboxypeptidase II (substance) |
| Dipeptidylpeptide hydrolase |
Dipeptidylpeptide hydrolase (substance) |
| Dipetalonema perstans |
Mansonella perstans (organism) |
| Diphenhydramine 2%/zinc acetate 0.1% topical cream |
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
| Diphenhydramine hydrochloride 12.5mg/5mL elixir |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Diphenhydramine hydrochloride 12.5mg/5mL syrup |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Diphenhydramine hydrochloride 6.25mg/5mL syrup |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
| Diphenhydramine hydrochloride 6.25mg/5mL syrup |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
| Diphenylmethane diisocyanate specific extract |
Diphenylmethane di-isocyanate |
| Diphtheria and tetanus double vaccination NOS |
Administration of diphtheria and tetanus vaccine |
| Diphtheria and tetanus double vaccination NOS |
Administration of diphtheria and tetanus vaccine |
| Diphtheria toxin skin test |
Diphtheria toxin |
| Diphtheria, pertussis and tetanus triple vaccination |
Administration of diphtheria, pertussis, and tetanus vaccine |
| Diphtheria, pertussis and tetanus triple vaccination NOS |
Administration of diphtheria, pertussis, and tetanus vaccine |
| Diphtheria, pertussis and tetanus triple vaccination NOS |
Administration of diphtheria, pertussis, and tetanus vaccine |
| Dipivefrin hydrochloride 0.1% eye drops |
Dipivefrine hydrochloride 1 mg/mL eye solution |
| Dipivefrin hydrochloride 0.1% ophthalmic solution |
Dipivefrine hydrochloride 1 mg/mL eye solution |
| Dipivefrin hydrochloride 0.1%wv solution |
Dipivefrine hydrochloride 1 mg/mL eye solution |
| Direct invasion of adrenal (T3a) |
American Joint Committee on Cancer cT3a (qualifier value) |
| Direct laryngoscopy with injection into vocal cord, therapeutic |
Direct laryngoscopy with injection into vocal cord (procedure) |
| Direct laryngoscopy, diagnostic, newborn |
Direct laryngoscopy |
| Direct laryngoscopy, diagnostic, with operating microscope |
Direct laryngoscopy with operating microscope (procedure) |
| milieu malpropre |
Dirty environment (finding) |
| Disability assessment schedule |
World Health Organization Disability Assessment Schedule 2.0 (assessment scale) |
| Disabled relative |
Family history of disability |
| Discharge from suture line |
Discharge from suture line (finding) |
| Discogram |
Discography with injection of contrast into intervertebral disc |
| Discogram |
Discography with injection of contrast into intervertebral disc |
| Discogram |
Discography with injection of contrast into intervertebral disc |
| Discography of cervical spine using fluoroscopic guidance |
Fluoroscopic discography with injection of contrast into intervertebral disc of cervical spine (procedure) |
| Discography of thoracic spine using fluoroscopic guidance |
Fluoroscopic discography with injection of contrast into intervertebral disc of thoracic spine |
| Disease caused by Fimbriariidae |
Disease caused by Fimbriidae (disorder) |
| Disease caused by Thysanosomidae |
Disease caused by Thysanosomatinae (disorder) |
| Disease caused by superfamily Syngamoidea |
Disease due to family Syngamidae |
| Disease due to Cestoda |
Cestode infection |
| Disease due to Orthopoxviridae |
Disease due to Orthopoxvirus |
| Disease due to Parapoxviridae |
Disease due to Parapoxvirus |
| Disease due to Reovirus |
Disease due to Orthoreovirus |
| Disease due to Trematoda |
Trematode infection |
| Disease of biliary tract |
Disorder of biliary tract |
| Disease of endocrine gland |
Disorder of endocrine gonad |
| Disease of supporting structures of teeth |
Periodontal disease |
| Disease of teeth |
Tooth disorder |
| Disease of thymus gland, NEC |
Disorder of thymus gland |
| Disinhibition caused by ingestible alcohol |
Disinhibition caused by ethanol |
| Disodium edetate allergy |
Allergy to edetate (finding) |
| Disodium etidronate adverse reaction |
Adverse reaction to etidronic acid |
| Disodium etidronate allergy |
Allergy to etidronic acid (finding) |
| Disodium etidronate and calcium carbonate allergy |
Allergy to etidronic acid (finding) |
| Disodium pamidronate adverse reaction |
Adverse reaction to pamidronic acid (disorder) |
| Disodium pamidronate allergy |
Allergy to pamidronic acid (finding) |
| Disodium tiludronate |
Product containing tiludronic acid (medicinal product) |
| Disopyramide phosphate 100mg capsule |
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
| Disopyramide phosphate 100mg m/r capsule |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 100mg m/r tablet |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 100mg prolonged-release oral capsule |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 100mg prolonged-release oral tablet |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 150mg |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
| Disopyramide phosphate 150mg capsule |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
| Disopyramide phosphate 150mg m/r capsule |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 150mg prolonged-release oral capsule |
Disopyramide only product in oral dose form |
| trouble selon la localisation corporelle |
Disease |
| Disorder involving the integument of fetus or newborn, NEC |
Disorder involving the integument of fetus OR newborn |
| Disorder of amino acid transport |
Amino acid transport disorder |
| Disorder of autonomic nervous system caused by substance |
Disorder of autonomic nervous system |
| Disorder of balance |
Impairment of balance (finding) |
| Disorder of heart caused by Salmonella enterica subspecies enterica serovar Typhi |
Infection of heart caused by Salmonella enterica subspecies enterica serovar Typhi (disorder) |
| Disorder of hemostasis |
Blood coagulation disorder |
| Disorder of iris AND/OR ciliary body |
Disorder of uveal tract |
| Disorder of pregnancy |
Disorder of pregnancy |
| Disorder of skeletal muscle |
Disorder of skeletal muscle |
| Disorder of transport, NEC |
Metabolic disorder of transport |
| trouble présent principalement avec la chorée |
Chorea |
| Dispensing of unlisted low vision aid |
Fitting and dispensing of spectacles |
| Displaced tooth |
Displaced tooth |
| Displacement - action |
Action |
| Displacement of breast implant |
Displacement of prosthetic breast implant (disorder) |
| Displacement, first degree |
Displacement |
| Displacement, second degree |
Displacement |
| Displacement, third degree |
Displacement |
| Disproportion of other origin, NEC |
Disproportion between fetus and pelvis (disorder) |
| Disrupted episiotomy wound |
Disruption of episiotomy wound in the puerperium (disorder) |
| Disrupted laceration wound site |
Disrupted wound |
FHIR